Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_assertion type Assertion NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_head.
- NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_assertion description "[So we believe that the elimination of the immunogenicity of CAR might prolong the persistence of CAR expressing T cells in vivo and put forward a hypothesis that the antigen binding portion of CAR could be derived from the antibody against osteosarcoma antigen from the same patient with osteosarcoma by methods such as antibody phage display, BRASIL technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_provenance.
- NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_assertion evidence source_evidence_literature NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_provenance.
- NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_assertion SIO_000772 22330890 NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_provenance.
- NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_assertion wasDerivedFrom befree-20140225 NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_provenance.
- NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_assertion wasGeneratedBy ECO_0000203 NP924132.RAuCJfIlKkfgyUK_VrDiW_iL2rCus2_gcgTVtIeC3RPhs130_provenance.